Literature DB >> 9607177

Alpha-adducin polymorphisms and renal sodium handling in essential hypertensive patients.

P Manunta1, D Cusi, C Barlassina, M Righetti, C Lanzani, M D'Amico, L Buzzi, L Citterio, P Stella, R Rivera, G Bianchi.   

Abstract

The relationship between blood pressure and sodium (Na) excretion is less steep in hypertension caused by increased renal tubular reabsorption. We recently demonstrated that one mutation in rat alpha-adducin gene: (1) is responsible for approximately 50% of the hypertension of MHS rats, and (2) stimulates tubular Na-K pump activity when transfected in renal epithelial cell, suggesting that its pressor effect may occur because an increased tubular reabsorption. Linkage and association studies demonstrated that the alpha-adducin locus is relevant for human hypertension. A point mutation (G460W) was found in human alpha-adducin gene, the 460W variant (G/W) is more frequent in hypertensives than in normotensives. The aim of this study was to test whether acute changes in body Na may differently affect blood pressure in humans as a function of alpha-adducin genotype. The pressure-natriuresis relationship was analyzed in 108 hypertensive using two different acute maneuvers: Na removal (furosemide 25 mg p.o.) and, two days later, Na load (310 mmoles i.v. in 2 hr). We found that 80 patients were wild-type homozygous (G/G), 26 were G/W heterozygous, and 2 were W/W homozygous with similar blood pressure, age body mass index, gender, plasma and urinary sodium and potassium. In basal condition G/W-W/W patients showed a lower plasma renin activity and fractional excretion of Na. In either case the pressure-natriuresis relationship was less sleep in G/W-W/W than in G/G patients, obviously negative for Na depletion with furosemide (-0.011 +/- 0.004 vs. -0.002 +/- 0.002 mm Hg/mumol/min, P < 0.03), and positive for Na load (0.086 +/- 0.02 vs. 0.027 +/- 0.007 mm Hg/mumol/min, P < 0.001). The finding of reduced slope after Na depletion or Na load supports the hypothesis that, as MHS rats, humans bearing one W alpha-adducin variant display an increased of renal tubular sodium reabsorption.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9607177     DOI: 10.1046/j.1523-1755.1998.00931.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  27 in total

Review 1.  Drug-gene interactions between genetic polymorphisms and antihypertensive therapy.

Authors:  Hedi Schelleman; Bruno H Ch Stricker; Anthonius De Boer; Abraham A Kroon; Monique W M Verschuren; Cornelia M Van Duijn; Bruce M Psaty; Olaf H Klungel
Journal:  Drugs       Date:  2004       Impact factor: 9.546

2.  Strategies to improve detection of hypertension genes.

Authors:  Steven C Hunt
Journal:  J Nutrigenet Nutrigenomics       Date:  2011-04-06

Review 3.  Genetic architecture of complex traits predisposing to nephropathy: hypertension.

Authors:  Steven C Hunt
Journal:  Semin Nephrol       Date:  2010-03       Impact factor: 5.299

4.  Claudin-14 Gene Polymorphisms and Urine Calcium Excretion.

Authors:  Teresa Arcidiacono; Marco Simonini; Chiara Lanzani; Lorena Citterio; Erika Salvi; Cristina Barlassina; Donatella Spotti; Daniele Cusi; Paolo Manunta; Giuseppe Vezzoli
Journal:  Clin J Am Soc Nephrol       Date:  2018-09-19       Impact factor: 8.237

Review 5.  The genomics of cardiovascular disorders: therapeutic implications.

Authors:  P Ferrari; G Bianchi
Journal:  Drugs       Date:  2000-05       Impact factor: 9.546

6.  Klotho Gene in Human Salt-Sensitive Hypertension.

Authors:  Lorena Citterio; Simona Delli Carpini; Sara Lupoli; Elena Brioni; Marco Simonini; Simone Fontana; Laura Zagato; Elisabetta Messaggio; Cristina Barlassina; Daniele Cusi; Paolo Manunta; Chiara Lanzani
Journal:  Clin J Am Soc Nephrol       Date:  2020-01-28       Impact factor: 8.237

7.  NKCC2 is activated in Milan hypertensive rats contributing to the maintenance of salt-sensitive hypertension.

Authors:  Monica Carmosino; Federica Rizzo; Patrizia Ferrari; Lucia Torielli; Mara Ferrandi; Giuseppe Bianchi; Maria Svelto; Giovanna Valenti
Journal:  Pflugers Arch       Date:  2011-05-07       Impact factor: 3.657

Review 8.  Gene markers and antihypertensive therapy.

Authors:  Stephen T Turner; Gary L Schwartz
Journal:  Curr Hypertens Rep       Date:  2005-02       Impact factor: 5.369

9.  Alpha-adducin Gly460Trp polymorphism and hypertension risk: a meta-analysis of 22 studies including 14303 cases and 15961 controls.

Authors:  Kuo Liu; Jielin Liu; Yan Huang; Ya Liu; Yuqing Lou; Zuoguang Wang; Hong Zhang; Shan Yan; Zhizhong Li; Shaojun Wen
Journal:  PLoS One       Date:  2010-09-28       Impact factor: 3.240

10.  Novel genetic variants in the alpha-adducin and guanine nucleotide binding protein beta-polypeptide 3 genes and salt sensitivity of blood pressure.

Authors:  Tanika N Kelly; Treva K Rice; Dongfeng Gu; James E Hixson; Jing Chen; Depei Liu; Cashell E Jaquish; Lydia A Bazzano; Dongsheng Hu; Jixiang Ma; C Charles Gu; Jianfeng Huang; L Lee Hamm; Jiang He
Journal:  Am J Hypertens       Date:  2009-07-02       Impact factor: 2.689

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.